Myriam Chalabi
@MyriamChalabi
Medical Oncologist, GI cancers @nki_nl neoadjuvant #immunotherapy #cancerresearch. Opinions my own
ID:1054645155389718528
23-10-2018 08:06:14
1,5K Tweets
5,4K Followers
481 Following
Het Antoni van Leeuwenhoek heeft twaalf prachtige IC kamers, waar patiënten herstellen na een complexe chirurgische ingreep of systemische behandeling. Eén van de kamers wordt gebruikt voor o.a. BLS training van de medewerkers.
Please consider submitting to this special issue on Cell Therapy ESMO IOTECH John Haanen led by Alena Gros
Full house with PhD’s, postdocs and PI’s. Inspiring Entrepreneur Club lectures “A glimpse into the future” on the pros and cons of Pharma-Academia partnerships, by Marleen Kok, Emile Voest, Ton Schumacher and René Bernards. The Netherlands Cancer Institute MarleenKokLab
Calling ALL women in GI Oncology!! 📣As #GI24 approaches, I can’t wait for this event! Let’s amplify, uplift, elevate - because We Go Together! Pamela Kunz, MD Kristen Spencer Aparna Raj Parikh Aparna Kalyan MD Hematology & Oncology Women Physicians Group—HOWPG Women in Oncology Shikha Jain MD, FACP
Register now:
tinyurl.com/7rm93mwx
🌟New #neoadjuvant #immunotherapy trial in Nature Medicine today -- work led by Myriam Chalabi The Netherlands Cancer Institute. Check out the paper and 🧵 below. Congrats to all the authors!
Check out our latest work, out today in Nature Medicine. Special thanks to Saheli Sadanand for handling our manuscript and for the always fantastic interaction! And to all reviewers Anwaar Saeed (non-anonymous reviewer)for further improving our manuscript The Netherlands Cancer Institute
A neoadjuvant treatment regimen of anti-PD-L1 #immunotherapy followed by anti-PD-L1 + chemotherapy was well tolerated and led to pathologic response rate of 70% in patients with resectable #GastricCancer or GEJ adenocarcinoma Myriam Chalabi The Netherlands Cancer Institute
nature.com/articles/s4159…